Effects of a transitional care programme on medication adherence in an older cardiac population: A randomized

Sara Daliri1,2, Marcel J Kooij3, Wilma J M Scholte Op Reimer4,5

  • 1Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, The Netherlands.

Insights

The Cardiac Care Bridge intervention did not improve medication adherence in older cardiac patients after hospital discharge. However, a potential benefit was observed in patients not using multidose drug dispensing systems.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Medication non-adherence is prevalent in older adults with chronic conditions post-discharge, leading to adverse health outcomes.
  • Effective interventions are crucial to improve medication adherence and reduce hospital readmissions in this vulnerable population.

Purpose of the Study:

  • To evaluate the impact of the Cardiac Care Bridge (CCB) intervention on medication adherence in elderly cardiac patients following hospital discharge.
  • To identify factors influencing medication adherence in the post-discharge setting.

Main Methods:

  • Secondary analysis of a randomized single-blind trial involving patients aged 70 years and older admitted to cardiology departments.
  • The CCB intervention included medication reconciliation, identification of medication-related problems (MRPs) by community nurses, and pharmacist recommendations.
  • Medication adherence was measured by the proportion of days covered (PDC) using pharmacy refill data.

Main Results:

  • The CCB intervention did not significantly improve medication adherence (PDC) in the overall study population.
  • A trend towards improved adherence was noted in patients not utilizing multidose drug dispensing (MDD) systems (Pinteraction = 0.085).
  • A high prevalence of medication-related problems (MRPs) was observed in 77.0% of patients post-discharge.

Conclusions:

  • The multi-component CCB intervention did not demonstrate a significant benefit in improving medication adherence for older cardiac patients post-discharge.
  • Further research is warranted to confirm the potential adherence benefits in non-MDD users.
  • Addressing medication-related problems remains critical for this patient group.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
46
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
34
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
51
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
97
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
35